AVANDAMET - 0173-0840-18 - (rosiglitazone maleate and metformin hydrochloride)

Alphabetical Index


Drug Information of AVANDAMET

Product NDC: 0173-0840
Proprietary Name: AVANDAMET
Non Proprietary Name: rosiglitazone maleate and metformin hydrochloride
Active Ingredient(s): 1000; 4    mg/1; mg/1 & nbsp;   rosiglitazone maleate and metformin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of AVANDAMET

Product NDC: 0173-0840
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021410
Marketing Category: NDA
Start Marketing Date: 20110524

Package Information of AVANDAMET

Package NDC: 0173-0840-18
Package Description: 60 TABLET, FILM COATED in 1 BOTTLE (0173-0840-18)

NDC Information of AVANDAMET

NDC Code 0173-0840-18
Proprietary Name AVANDAMET
Package Description 60 TABLET, FILM COATED in 1 BOTTLE (0173-0840-18)
Product NDC 0173-0840
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rosiglitazone maleate and metformin hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110524
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
Strength Number 1000; 4
Strength Unit mg/1; mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of AVANDAMET


General Information